LEI NIE to Thalidomide
This is a "connection" page, showing publications LEI NIE has written about Thalidomide.
Connection Strength
0.027
-
FDA Drug Approval: Elotuzumab in Combination with Lenalidomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma. Clin Cancer Res. 2017 Nov 15; 23(22):6759-6763.
Score: 0.027
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.